After treatment with monoclonal antibodies against VEGF, such as bevacizumab, patient prognosis did not reach statistical significance, and patients suffered strongly adverse reactions [ 6 ].
← all excerpts
AQP5 complements LGR5 to determine the fates of gastric cancer stem cells through regulating ULK1 ubiquitination.
1
—
—